But if his knowledge of this type of cancer is limited, it can possibly set him on the wrong track of knowing how best to fight it.
This Biotech Finds Its Stride With Kidney Cancer Treatment
The South San Francisco-based biotech has notched a series of achievements in recent months — posting first-time operating profit, confirming the effectiveness of its breakout compound for treating kidney cancer and retiring nearly all its debt.
No comments:
Post a Comment